Field trials on a live bovine respiratory syncytial virus vaccine in calves.

Immunology of bovine respiratory syncytial virus in calves.

Further investigations of live respiratory syncytial virus vaccine administered parenterally.

Effect of serum and nasal neutralizing antibodies on bovine respiratory syncytial virus infection in calves.

Progress toward a Respiratory Syncytial Virus Vaccine.

Live-attenuated respiratory syncytial virus vaccines.

Detection of antibody to bovine syncytial virus and respiratory syncytial virus in bovine fetal serum.

Universal vaccine against respiratory syncytial virus A and B subtypes.

A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Reinfection of lambs with bovine respiratory syncytial virus.

Bovine respiratory syncytial virus: infection dynamics within and between herds.

Evidence of immunosuppression by bovine respiratory syncytial virus.

Human and bovine respiratory syncytial virus: immunopathologic mechanisms.

Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.

Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.

Effects of recombinant human alpha A interferon in gnotobiotic calves challenged with respiratory syncytial virus.

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.

Serological titers to bovine herpesvirus 1, bovine viral diarrhea virus, parainfluenza 3 virus, bovine respiratory syncytial virus and Pasteurella haemolytica in feedlot calves with respiratory disease: associations with bacteriological and pulmonary cytological variables.

Occurrence and phylogenetic analysis of bovine respiratory syncytial virus in outbreaks of respiratory disease in Norway.

Respiratory syncytial virus infections.

A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.

Studies on the occurrence and significance of bovine respiratory syncytial virus in Saskatchewan.

Incorporating founder virus information in vaccine field trials.

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.

Suggest Documents

Immunology of bovine respiratory syncytial virus in calves.

Further investigations of live respiratory syncytial virus vaccine administered parenterally.

Effect of serum and nasal neutralizing antibodies on bovine respiratory syncytial virus infection in calves.

Progress toward a Respiratory Syncytial Virus Vaccine.

Live-attenuated respiratory syncytial virus vaccines.

Detection of antibody to bovine syncytial virus and respiratory syncytial virus in bovine fetal serum.

Universal vaccine against respiratory syncytial virus A and B subtypes.

A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Reinfection of lambs with bovine respiratory syncytial virus.

Bovine respiratory syncytial virus: infection dynamics within and between herds.

Evidence of immunosuppression by bovine respiratory syncytial virus.

Human and bovine respiratory syncytial virus: immunopathologic mechanisms.

Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.

Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.

Effects of recombinant human alpha A interferon in gnotobiotic calves challenged with respiratory syncytial virus.

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.

Serological titers to bovine herpesvirus 1, bovine viral diarrhea virus, parainfluenza 3 virus, bovine respiratory syncytial virus and Pasteurella haemolytica in feedlot calves with respiratory disease: associations with bacteriological and pulmonary cytological variables.

Occurrence and phylogenetic analysis of bovine respiratory syncytial virus in outbreaks of respiratory disease in Norway.

Respiratory syncytial virus infections.

A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.

Studies on the occurrence and significance of bovine respiratory syncytial virus in Saskatchewan.

Incorporating founder virus information in vaccine field trials.

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.

Field trials on a live bovine respiratory syncytial virus vaccine in calves.

Recommend Documents

Follow Us